Clinical Trial Eligibility and Outcomes in Patients With Metastatic NSCLC Treated Outside of Clinical Trials.

Autor: Oakley CK, Yellala A, Tulpule S, High R, Ganti AK, Marr AS

Publikováno v: Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2024 Dec 03; Vol. 38 (12), pp. 462-468.

Single nucleotide seed modification restores in vivo tolerability of a toxic artificial miRNA sequence in the mouse brain.

Autor: Monteys AM; The Center for Cell and Molecular Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Spengler RM; Internal Medicine, University of Iowa, Iowa City, IA 52242, USA., Dufour BD; Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR 97006, USA Department of Behavioral Neuroscience, Oregon Health Sciences University, Portland, OR 97239, USA., Wilson MS; Internal Medicine, University of Iowa, Iowa City, IA 52242, USA., Oakley CK; Internal Medicine, University of Iowa, Iowa City, IA 52242, USA., Sowada MJ; The Center for Cell and Molecular Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., McBride JL; Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR 97006, USA Department of Behavioral Neuroscience, Oregon Health Sciences University, Portland, OR 97239, USA., Davidson BL; The Center for Cell and Molecular Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA davidsonbl@email.chop.edu.

Publikováno v: Nucleic acids research [Nucleic Acids Res] 2014 Dec 01; Vol. 42 (21), pp. 13315-27. Date of Electronic Publication: 2014 Oct 20.